| Literature DB >> 25819754 |
Maciej Banach1, Wilbert S Aronow2, Corina Serban3, Amirhossein Sahabkar4, Jacek Rysz5, Luminita Voroneanu6, Adrian Covic6.
Abstract
This paper is an effort to review all the most important studies and guidelines in the topics of lipid, blood pressure and kidney published in 2014. Irrespective of advances, the options for improving simultaneous hypercholesterolemia and hypertension management (as well as its complication - chronic kidney disease) remain a problem. Recommending hypolidemic, hypotensive and kidney disease drugs to obtain therapy targets in cardiovascular, diabetic, elderly and kidney disease (=high risk) patients might strengthen risk factor control, improve compliance and the therapy efficacy, and in the consequence reduce the risk of cardiovascular events and mortality rate. That is why the authors have decided to summary and discuss the recent scientific achievements in the field of lipid, blood pressure and kidney.Entities:
Keywords: Blood pressure; Cholesterol; Dyslipidemia; Hypertension; Lipids; Renal disease; Statin intolerance statin myopathy
Mesh：
Substances：
Year: 2015 PMID： 25819754 DOI： 10.1016/j.phrs.2015.03.009
Source DB: PubMed Journal: Pharmacol Res ISSN： 1043-6618 Impact factor: 7.658